GE Danaher Prices $3.97B Senior Notes Offering The company plans to use the financing to fund part of its 21.4 billion pending acquisition of GE Biopharma. Danaher Q3 Revenues Up 4 Percent The company's life sciences revenues were up 6 percent while its diagnostics business grew almost 7 percent. Danaher Offering €6.20B in Senior Notes The company announced its European subsidiary priced an offering of €6.20 billion ($6.83 billion) in senior notes to fund part of its purchase of GE's Biopharma business. Life Sciences, Diagnostics Drive Danaher Q2 Revenues Up 4 Percent Danaher's life sciences revenues grew 6 percent, while its diagnostics revenues rose nearly 5 percent, including an increase of more than 20 percent at Cepheid. Cowen Initiates Coverage of Horizon Discovery at Outperform The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic. Apr 14, 2015 Veracyte Inks Research Collaboration with GE Aug 15, 2013 U of Washington, GE Spearhead Effort to Develop Isothermal Amplification-based MDx for Point of Care Premium Jun 26, 2013 UW Leads $10M DoD-funded Project to Develop Paper-based Remote MDx Device Jan 30, 2013 IP Watch: Mayo Clinic, GE, Life Tech, TriLink, Penn State, Exact Sciences Win US Patents Premium Jan 18, 2013 Life Technologies' Stock Jumps on Reports of Potential Leveraged Buyout or Sale Aug 10, 2012 BG Medicine Revenues Jump to $622K in Q2; Firm Withdraws CardioScore 510(k) Premium Apr 30, 2012 GE Grant Funds Moffitt Breast Cancer Metastasis Marker Study Aug 10, 2011 IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Aug 10, 2011 Premium Aug 11, 2010 As Castellani Takes PhRMA's Helm, Where Does Personalized Medicine Advocacy Stand? Premium Mar 16, 2010 GE Researchers Plan to Sequence Single DNA Molecules Using “Closed Complex” Chemistry Soon Premium Oct 8, 2009 Helicos, Pacific Biosciences Get '$1,000 Genome' Stimulus Funds May 1, 2009 BioRegion Newsmakers: May 1, 2009 Premium Mar 16, 2009 Trading in Nanogen Stock Likely to be Suspended Next Week Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.